1 Min Read
Dec 4 (Reuters) - Galectin Therapeutics Inc:
* GALECTIN THERAPEUTICS TO PRESENT RESULTS FROM PHASE 2B NASH-CX TRIAL ON DECEMBER 5, 2017 Source text for Eikon: Further company coverage: (Bangalore.firstname.lastname@example.org)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.